| Ocular toxicity of belantamab mafodotin, an oncological perspective of management in relapsed and refractory multiple myeloma A Wahab, A Rafae, K Mushtaq, A Masood, H Ehsan, M Khakwani, A Khan Frontiers in Oncology 11, 678634, 2021 | 53 | 2021 |
| Treatment of light chain deposition disease: a systematic review A Masood, H Ehsan, Q Iqbal, A Salman, H Hashmi Journal of Hematology 11 (4), 123, 2022 | 12 | 2022 |
| Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient—a case report A Masood, A Wahab, T Clifford, EJ Weaver, H Ehsan, W El Ayass Clinical Case Reports 9 (12), e05184, 2021 | 10 | 2021 |
| Profile and management of toxicity of selinexor and belantamab mafodotin for the treatment of triple class refractory multiple myeloma K Neupane, A Wahab, A Masood, T Faraz, S Bahram, H Ehsan, A Hannan, ... Journal of Blood Medicine, 529-550, 2021 | 9 | 2021 |
| Outcomes of autologous stem cell transplantation in patients with ultra-high-risk multiple myeloma O Pasvolsky, S Ghanem, DR Milton, A Masood, MR Tanner, Q Bashir, ... Transplantation and Cellular Therapy 29 (12), 757-762, 2023 | 7 | 2023 |
| Lenalidomide-based maintenance after autologous hematopoietic stem cell transplantation for patients with high-risk multiple myeloma O Pasvolsky, DR Milton, M Rauf, MR Tanner, Q Bashir, S Srour, G Tang, ... Transplantation and Cellular Therapy 28 (11), 752. e1-752. e6, 2022 | 7 | 2022 |
| Role of Venetoclax in the treatment of relapsed and refractory multiple myeloma H Ehsan, A Wahab, Z Shah, MK Sana, A Masood, A Rafae, H Hashmi Journal of Hematology 10 (3), 89, 2021 | 7 | 2021 |
| Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4; 14): The MD Anderson Cancer Center Experience O Pasvolsky, MR Gaballa, DR Milton, A Masood, SS Sami, MR Tanner, ... Transplantation and cellular therapy 29 (4), 260. e1-260. e6, 2023 | 6 | 2023 |
| Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients O Pasvolsky, DR Milton, M Rauf, S Ghanem, A Masood, AH Mohamedi, ... Blood cancer journal 13 (1), 68, 2023 | 5 | 2023 |
| Efficacy and safety of allogeneic hematopoietic stem cell transplant in adults with hemophagocytic lymphohistiocytosis: a systematic review of literature A Masood, A Wahab, Q Iqbal, J Davis, H Ehsan, H Hashmi Bone Marrow Transplantation 57 (6), 866-873, 2022 | 5 | 2022 |
| Zinc-induced hypocupremia and pancytopenia, from zinc supplementation to its toxicity, a case report A Wahab, K Mushtaq, A Khan, MSK Khakwani, A Masood, J Henderson, ... Journal of Community Hospital Internal Medicine Perspectives 11 (6), 843-846, 2021 | 4 | 2021 |
| Leukemic stem cells and advances in hematopoietic stem cell transplantation for acute myeloid leukemia: A narrative review of clinical trials V Sumbly, I Landry, C Sneed, Q Iqbal, A Verma, T Dhokhar, A Masood, ... Stem Cell Investigation 9, 2022 | 3 | 2022 |
| Management of myeloproliferative neoplasms during pregnancy: a systematic review K Neupane, T Faraz, A Masood, V Aryal, S Bahram, L Khalid, N Hanif, ... Blood 138, 4642, 2021 | 1 | 2021 |
| Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis R Khanam, M Shahzad, SG Chaudhary, F Ali, Z Shah, PS Pachika, ... Leukemia & Lymphoma 63 (11), 2671-2678, 2022 | | 2022 |
| Efficacy and the safety of endoscopic ultrasound guided radiofrequency ablation of pancreatic cancer: A systematic review and meta-analysis. H Ehsan, A Masood, A Wahab, Z Ahmed, D Franco, A Rafae, MN Yousaf Journal of Clinical Oncology 40 (16_suppl), e16276-e16276, 2022 | | 2022 |
| Emerging immuno-therapies for advanced pancreatic cancer: An overview of available literature. A Masood, H Ehsan, Q Iqbal, SN Amin, M Wilson Journal of Clinical Oncology 40 (16_suppl), e16231-e16231, 2022 | | 2022 |
| Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review H Ehsan, A Rafae, A Masood, A Wahab, MK Sana, I Ansar, K Neupane, ... Clinical Lymphoma Myeloma and Leukemia 22 (5), e285-e292, 2022 | | 2022 |
| Role of Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis: A Systematic Review A Masood, H Ehsan, Q Iqbal, SN Amin, JA Davis, H Hashmi 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | | 2022 |
| Outcomes with Venetoclax in Relapsed Acute Myeloid Leukemia after Allogenic Hematopoietic Stem Cell Transplantation: A Systemic Review and Meta-Analysis PS Pachika, M Shahzad, R Khanam, A Masood, Z Ahmed, SF Ali, ... Blood 138, 4410, 2021 | | 2021 |
| Healthcare access disparity among US cancer population and evaluation of social determinants of health using NHANES data for 2013-18. A Wahab, A Rafae, K Mushtaq, A Masood, H Ehsan, M Khakwani, A Khan, ... Journal of Clinical Oncology 39 (15_suppl), e18527-e18527, 2021 | | 2021 |
